W. H. Wilson Tang, MD, is a staff cardiologist in the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute, Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Director of Cardiomyopathy Program at the Cleveland Clinic, as well as Research Director of the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. Dr. Tang’s specialty interests include cardiomyopathy, heart failure, heart transplantation and mechanical circulatory assist devices, and cancer-related heart diseases.
Dr. Tang graduated magna cum laude with a Bachelor of Science degree from Brown University in Rhode Island, where he received an honorary one-year period of study of the natural sciences at Jesus College, Cambridge University, in England. Dr. Tang received his medical degree from Harvard Medical School, and completed his internship and residency in internal medicine and a research fellowship in heart failure at Stanford University Medical Center. This was followed by clinical cardiology fellowship training at the Cleveland Clinic, and an advanced clinical fellowship in heart failure and cardiac transplantation. He was appointed to Cleveland Clinic in 2004 as a Staff Physician in the Section of Heart Failure and Cardiac Transplantation Medicine. He is board-certified in internal medicine, cardiovascular medicine, and advanced heart failure and transplant cardiology. Dr. Tang is a Fellow of the American College of Cardiology (ACC) and a Fellow of the American Heart Association (AHA), and has committee appointments in the Heart Failure Society of America (HFSA). He serves as member of the writing committee for both ACC/AHA and HFSA clinical guidelines in the management of heart failure. He is also a member of the International Society of Heart and Lung Transplantation.
Dr. Tang is a clinician-scientist interested in clinical translational research, with joint appointments with the Department of Cell Biology and the Genomic Medicine Institute at Cleveland Clinic's Lerner Research Institute. His research has been funded by grants from American Heart Association, American College of Cardiology, and the National Institutes of Health (NIH). As the Medical Director for the Center for Cardiovascular Diagnostics and Prevention, he is leading the Cleveland GeneBank Study as well as the Cleveland Heart and Metabolic Prevention Study (CHAMPS) to investigate novel mechanisms in the development of heart diseases. Dr. Tang also has leadership roles in the NIH-sponsored Clinical and Translational Sciences Collaborative, particularly in the operations of the Clinical Research Unit Services and the Pilot Grant Program. Dr. Tang’s current research interests include the role of nitrative stress and counter-regulatory mechanisms in the development and progression of heart failure, integrative genomics and metabolomics in cardiomyopathy, cardio-renal physiology, and device-based treatment and remote monitoring in heart failure disease management. Dr. Tang is currently the Principal Investigator for the Cleveland Heart Failure Network as part of the National Heart Failure Clinical Research Network for translational clinical trials. Dr. Tang also serves as the Associate Director for Heart Failure Trials of C5Research, the academic research organization for the coordination of multicenter clinical trials.
Dr. Tang has authored over 250 published peer-reviewed manuscripts in medical and scientific journals as well as chapters in medical textbooks. He is currently Associate Editor for Journal of Cardiac Failure and Cardiovascular Therapeutics, and serves as active member of the Editorial Boards for Journal of the American College of Cardiology, Circulation Heart Failure, American Heart Journal, Progressive in Cardiovascular Diseases, and Congestive Heart Failure.